Trial Examines Prostate Cancer Treatment with Reduced Side Effects

Why it matters locally: While the trial was conducted by the NHS, its findings on focal therapy for prostate cancer could significantly influence treatment protocols and patient options for the nearly 40 million residents of California, particularly given the state's diverse population and significant healthcare infrastructure.

A ten-year trial conducted by the NHS monitored nearly 3,500 men who underwent focal therapy for prostate cancer. This less invasive treatment method was the subject of the study, which spanned a decade.